TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/7/23 16:06 | 7/6/23 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Al-Wakeel Yasir B. | CA | O | CFO | S | -17 | 1.75 | 0 | -10 | -3 | 346 | D | ||||||||||||||
2/24/23 21:34 | 2/24/23 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Al-Wakeel Yasir B. | CA | O | CFO | S | -16 | 1.74 | 0 | -9 | -2 | 356 | D | ||||||||||||||
10/16/20 15:38 | 10/14/20 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Al-Wakeel Yasir B. | CA | O | CFO | P | 100 | 19.00 | 0 | 5 | 16 | 37 | D | ||||||||||||||
7/18/18 16:38 | 7/17/18 | NTGN | Neon Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Al-Wakeel Yasir B. | MA | O | CFO | M.d | 100 | 5.80 | 0 | 17 | New | 17 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |